Pioneering trial aims to free kidney patients from lifelong drugs
NCT ID NCT06972069
Summary
This early-stage study is testing a new combination treatment designed to help the body accept a donated kidney without needing lifelong anti-rejection drugs. The treatment involves a special bone marrow infusion from the kidney donor, along with medications and low-dose radiation, given just before the transplant. Researchers will see if this approach is safe and if it allows patients to reduce or completely stop their immunosuppressant medications over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.